BUSINESS
Why India needs a comprehensive policy on OTC drugs
Many would be surprised that the term OTC doesn't exist as per Indian law. Neither the Drugs & Cosmetics Act, 1940 nor the Drugs & Cosmetics Rules, 1945 define OTC
BUSINESS
Natco's partner Mylan prevails over Teva in Copaxone patent litigation
Natco's partner Mylan went ahead and launched Copaxone 40 mg “at-risk” in US in October last year even as the patent litigation is still on. Any setbacks in the patent litigation could have led to significant damages among other remedies for both the companies.
BUSINESS
USFDA releases guidance to help generic drug makers copy complex ones
"These draft guidances are aimed at ensuring that we provide as much scientific and regulatory clarity as possible with respect to complex generic drugs," US FDA Commissioner Scott Gottlieb in a statement.
BUSINESS
UP govt woos pharma cos, private healthcare firms with mega parks, public private partnership model
The state has received an investment commitment of about Rs 5,000-6,000 crore from domestic and multinational pharma companies,
BUSINESS
Indian pharma market grows 9.7% in Q2FY19 on uptake across therapy segments
IPM grew close to 10 percent in first half of this financial year FY19, returning to the 10 percent growth of FY17.
BUSINESS
LifeCell rejigs biz after Centre restricts commercial stem cell banking
LifeCell had moved from a private stem cell bank to a community bank unlike a private bank that is exclusively meant for the use of the baby or its immediate family members
BUSINESS
How Indian stent maker SMT is taking the battle to MNC shores
The study called 'Talent trial' was one of the largest ever clinical train conducted by an Indian company overseas to test a medical device
BUSINESS
Gujarat pharma industry says business as usual, but seeks govt action against attacks on migrant workers
Gujarat is the manufacturing hub for pharmaceuticals, housing over 3,300 manufacturing units, including some of the large drug makers such as Sun Pharma, Torrent Pharmaceuticals, Cadila Healthcare and Intas, contributing around 28 percent of India's pharmaceutical exports.
BUSINESS
Why India can't drop the ball on polio-free status
Polio eradication is one of very few success stories that India can boast off, after small pox elimination.
BUSINESS
How Medikabazaar is trying to replicate Amazon model for hospital medical supplies
Medikabazaar has 15,000 active registered users that includes hospitals, clinics, diagnostic centres and individual doctors
BUSINESS
India may face medicine shortage after China cracks down on factories to check pollution
Media reports estimate 40 percent of all China factories have been shut down at some point in the last one year in order to be inspected by environmental bureau officials, resulting in missed orders and increased costs
BUSINESS
Torrent Pharma says charges of duping C&F agents baseless
The company spokesperson said that Torrent Pharma is not liable to pay outstanding dues to C&F agents before June 29, 2014 as per the business transfer agreement .
BUSINESS
US drug regulator issues guidance to tackle delays & speed-up generic approvals
In the latest draft guidance, USFDA tried to tackle a major loophole called 'citizen petitions' used by branded drug makers or innovators to delay the entry of generic drugs
BUSINESS
Holland's Wolter Kluwer bets on Indian healthcare to drive sales
The company gets about 70-80 percent of sales in India from healthcare.
BUSINESS
Dr Reddy's sells US penicillin plant to Abu Dhabi-based Neopharma
The sale of the plant is a part of the company's efforts to rein in costs as it faces intense pricing pressure in the US market, among other disadvantages
BUSINESS
Glenmark banks on complex and differentiated products to beat US pricing pressure
"Pricing pressure (in US) continues. I don't think we are going to see any moderation," Glenn Saldanha, Chairman and Managing Director of Glenmark, told Moneycontrol.
BUSINESS
Pharmacy strike: Medical stores cite job loss, drug abuse as risks from online sales
Union health ministry earlier this month notified rules that would allow online pharmacies to register and dispense all medicines
BUSINESS
Ayushman Bharat gets a boost as SC makes Aadhaar mandatory
"We would prefer to have Aadhaar, however will not deny services if there is no Aadhaar," said Indu Bhushan, Chief Executive Officer (CEO) of Pradhan Mantri Jan Arogya Yojana (PM-JAY) and NHA to Moneycontrol.
BUSINESS
Alcon sees huge potential in Indian eye care segment led by surge in cataract surgeries
India is home to around 30 percent of the world’s blind people, about half of whom are blind from cataracts.
BUSINESS
Will Modicare be a game changer or turn into another Rashtriya Swasthya Bima Yojana?
The scheme aims to provide Rs 5 lakh coverage to 100 million poor vulnerable families translating into 500 million individual beneficiaries, which is more than the population of North America
BUSINESS
The curious case of missing patients with J&J's ASR hip implant
J&J had earlier informed CDSCO that around 93,000 people worldwide had ASR implanted. And of the 4,700 ASR surgeries performed in India, just 882 patients could be traced
BUSINESS
Exclusive | Fully prepared for rollout with 31 states, 9,000 private hospitals on board: Ayushman Bharat CEO
"We are fully prepared, it's a big scheme, there is no start or end point, it's a continuum," said Indu Bhushan, CEO of Pradhan Mantri Jan Arogya Yojana and NHA
BUSINESS
Biocon closer to Europe approval of biosimilar pegfilgrastim
Amgen's Neulasta had brand sales of more than $450 million in Europe for the 12 months ending June 30, 2018, according to market research firm IQVIA.
BUSINESS
Exclusive | How Lupin plans to counter dwindling sales growth in Japan
Even as the company faces another price cut in Japan, Lupin looks to rationalise costs, shift manufacturing units and looks at non-Japanese markets to continue growth
